International Drugmakers Earn Warning Letters Over Quality Controls
The FDA issued warning letters to two international drug manufacturers for breaching GMP standards by failing to develop procedures to maintain the appropriate quality controls.
Source: International Pharmaceutical Regulatory Monitor